Episode Player
263: Why AI and Automation Tools Won't Deliver Until Your Lab's Data Is Connected with David Hardy - Part 1
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurdle.
David Hardy, a leading market and innovation strategist at Thermo Fisher Scientific with 25 years of experience at the intersection of data, automation, and laboratory science, is helping organizations bridge the gap between data chaos and actionable insight.
Topics discussed:
- David Hardy’s early experiences managing NMR data at AstraZeneca and the origins of his interest in data management (03:46)
- Lessons from retail analytics and returning to scientific data challenges (05:21)
- Identifying the persistent problem of data connectivity in labs, despite growing data volumes and new technologies (06:40)
- The most common pushbacks to digital solutions: long-term commitment and culture change (07:38)
- What mindsets and leadership approaches support successful digital transformation (08:43)
- Recognizing fragmentation and spotting “hidden” data silos in biotech labs (10:06)
- Where data fragmentation hurts the most—especially for cross-disciplinary questions and CMC reporting (11:06)
- Build vs. buy: deciding whether to create in-house digital tools or work with external vendors (13:50)
- The importance of adaptable systems and preparing for inevitable change in biotech data management (14:43)
Smart insight: True digital transformation is not a project, but a process—a way of working that requires vision, patience, and continual adaptation. The labs that break down data silos and connect their digital resources are better positioned to unlock the full promise of biotech: faster discoveries, more robust compliance, and therapies delivered to patients without unnecessary delay.
The connectivity problem doesn't stop at the data layer. These episodes tackle the automation failures, digital infrastructure decisions, and AI readiness questions that determine whether your lab's data ever becomes an asset.
- Episodes 215 - 216: From Data Silos to Autonomous Biomanufacturing: Digital Twins and AI-Driven Scale-Up with Ilya Burkov
- Episodes 233 - 234: Why Most Bioprocess Automation Projects Fail Before the Robot Is Even Ordered with Anthony Catacchio
- Episodes 153 - 154: The Future of Bioprocessing: Industry 4.0, Digital Twins, and Continuous Manufacturing Strategies with Tiago Matos
- Episodes 17 - 18: How Extracting Gold From Your Data Accelerates Process Development with Ioscani Jiménez del Val
Connect with David Hardy
LinkedIn: www.linkedin.com/in/david-hardy-46331823
Thermo Fisher Scientific website: www.thermofisher.com
Next step: If you enjoyed this episode, please leave a review on Apple Podcasts or your favorite podcast platform. By doing so, we can empower more scientists like you. Stay tuned for more inspiring biotech insights in our next episode.
